HBOT for Gas Gangrene / Clostridial Myonecrosis | NorCal Hyperbarics Concord, CA

Gas gangrene, or clostridial myonecrosis, is a rapidly progressive, life-threatening soft tissue infection caused by spore-forming, anaerobic Clostridium species — most commonly Clostridium perfringens. It develops when these organisms, ubiquitous in soil, the GI tract, and the environment, contaminate deep wounds and find the anaerobic, ischemic tissue environment they require to germinate from spore to vegetative form and begin producing their devastating toxin arsenal.

Gas gangrene can develop in any wound that creates an ischemic, oxygen-depleted tissue environment — including traumatic wounds (motor vehicle accidents, combat injuries, crush injuries), surgical wounds (particularly GI or orthopedic surgery), spontaneous myonecrosis (in immunocompromised or diabetic patients from endogenous GI clostridial translocation), or injection-site infections (in people who inject drugs). The clinical presentation is unmistakable once established: severe wound pain, rapidly spreading edema and discoloration, a foul-smelling wound discharge, crepitus from subcutaneous gas, and the rapid onset of systemic toxemia with fever, tachycardia, hemolytic anemia, and cardiovascular instability.

Gas gangrene is an approved UHMS indication for HBOT and is classified as one of the clearest emergency applications of hyperbaric medicine, alongside decompression sickness and carbon monoxide poisoning. The specific UHMS indication is "Clostridial Myositis and Myonecrosis."

Gas gangrene (clostridial myonecrosis) is the most severe form of clostridial infection and is distinguished from other necrotizing soft tissue infections by several features that make it uniquely responsive to HBOT: the causative organisms are obligate anaerobes that cannot survive oxygen, and their primary virulence factors — alpha-toxin and theta-toxin — are produced through oxygen-sensitive metabolic pathways. This means that HBOT is not merely adjunctive in the way it is for many other infections; it is specifically targeted at the precise mechanisms that make gas gangrene so destructive.

Clostridium perfringens type A, the most common causative organism, produces alpha-toxin (phospholipase C/lecithinase) that destroys cell membranes throughout the body, producing the characteristic hemolysis, myonecrosis, and cardiovascular failure of gas gangrene. It also produces theta-toxin (perfringolysin O), which directly damages cardiac and vascular endothelial cells. Both toxins are produced through strictly anaerobic metabolic pathways: at tissue oxygen tensions above 250 mmHg — which HBOT at 2.5 atmospheres achieves — toxin production is virtually eliminated within the first treatment session. Simultaneously, the bacteria themselves cannot survive in this oxygen-rich environment, directly suppressing bacterial replication in tissues that may be beyond surgical reach.

The recommended HBOT protocol for gas gangrene involves three sessions in the first 24 hours (the highest-intensity protocol in hyperbaric medicine) to maximize the immediate antimicrobial and anti-toxin benefit. HBOT is always used as an adjunct to — never a reason to delay — surgical débridement. The combination of early, aggressive surgery and HBOT beginning immediately after the first operative procedure offers the best published outcomes in terms of survival and limb preservation. Dr. Toth coordinates directly with surgical teams for urgent case management.